Aspirin

Generic Name: Aspirin

Brand Names: Aggrenox, Alka-seltzer, Alka-seltzer Fruit Chews, Anacin, Arthriten Inflammatory Pain, Ascomp, Aspi-cor, Aspir-low, Bayer Aspirin, Bayer Womens, Bc Arthritis, Bc Original Formula, Bufferin, Duoplavin, Durlaza, Ecotrin, Ecpirin, Endodan Reformulated May 2009, Equagesic, Exaprin, Excedrin, Excedrin PM Triple Action, Fasprin, Fiorinal, Goody's Body Pain, Goody's Extra Strength, Goody's PM, Miniprin, Norgesic, Norgesic Forte, Orphengesic, Pamprin Max Formula, Robaxisal, ST. Joseph Aspirin, Stanback Headache Powder Reformulated Jan 2011, Trianal, Trianal C, Vanquish, Vazalore, Yosprala

Drug Type: Small Molecule

Chemical Formula: C_₉H_₈O_₄

CAS Number: 50-78-2

Unique Ingredient Identifier: R16CO5Y76E

Background: Also known as Aspirin, acetylsalicylic acid (ASA) is a commonly used drug for the treatment of pain and fever due to various causes. Acetylsalicylic acid has both anti-inflammatory and antipyretic effects. This drug also inhibits platelet aggregation and is used in the prevention of blood clots stroke, and myocardial infarction (MI) .
...

Indication: Pain, fever, and inflammation
...

Associated Conditions: Acute Coronary Syndrome (ACS), Anxiety, Atherothrombotic cerebral infarction, Cardiovascular Disease (CVD), Cardiovascular Events, Cardiovascular Mortality, Colorectal Adenomas, Colorectal Cancer, Common Cold, Coronary artery reocclusion, Death, Dyspeptic signs and symptoms, Fever, Flu caused by Influenza, Headache, Heterozygous Familial Hypercholesterolemia (HeFH), Inflammation, Juvenile Idiopathic Arthritis (JIA), Major Adverse Cardiovascular and Cerebrovascular Events (MACCE), Menstrual Pain, Migraine, Morbidity, Mucocutaneous Lymph Node Syndrome, Muscle Contraction, Myalgia, Myocardial Infarction, Myocardial Infarction (MI), first occurrence, Neuropathic Pain, Pain, Pain caused by Common Cold, Pain caused by Rheumatism, Pericarditis, Polycythemia Vera (PV), Pre-Eclampsia, Rheumatism, Rheumatoid Arthritis, Rhino Sinusitis, Severe Pain, Spondyloarthropathies, Stroke, Systemic Lupus Erythematosus, Tension Headache, Thromboembolism, Thrombosis, Toothache, Transient Ischemic Attack, Vascular Death, Venous Thromboembolism, Acute Inflammation, Articular inflammation, Atherothrombotic events, Death caused by Myocardial Infarction, Fever or influenza-like illness, Moderate Pain, Recurrent Ischemic Stroke

Associated Therapies: Anti-platelet Therapy, Hemodialysis Treatment, Secondary Prevention

Clinical Trials

Clopidogrel and Aspirin Together: The Effect on C-Reactive Protein Trial

Phase 4

Completed

Conditions: Coronary Artery Disease

First Posted Date: 2006-06-23

Last Posted Date: 2008-08-21

Lead Sponsor: Intermountain Health Care, Inc.

Target Recruit Count: 100

Registration Number: NCT00343876

Locations: 🇺🇸
LDS Hospital, Salt Lake City, Utah, United States

Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting: The PAPA CABG Study

Phase 3

Completed

Conditions: Coronary Artery Disease
Coronary Artery Bypass Grafting

First Posted Date: 2006-05-29

Last Posted Date: 2017-08-03

Lead Sponsor: Hamilton Health Sciences Corporation

Target Recruit Count: 150

Registration Number: NCT00330772

Locations: 🇨🇦
Hamilton General Hospital, Hamilton, Ontario, Canada

Dexamethasone, Aspirin, and Diethylstilbestrol in Treating Patients With Locally Advanced or Metastatic Prostate Cancer

Phase 3

Completed

Conditions: Prostate Cancer

First Posted Date: 2006-04-21

Last Posted Date: 2013-06-26

Lead Sponsor: St. Bartholomew's Hospital

Target Recruit Count: 260

Registration Number: NCT00316927

Locations: 🇬🇧
Kent and Canterbury Hospital, Canterbury, England, United Kingdom
🇬🇧
Chelsea Westminster Hospital, London, England, United Kingdom
🇬🇧
Milton Keynes General Hospital, Milton Keynes, England, United Kingdom

and more 12 locations

Pioglitazone vs Placebo in Combination With Niacin Extended Release on Low HDL

Phase 2

Completed

Conditions: Metabolic Syndrome

Interventions: Drug: Pioglitazone
Other: Placebo
Drug: Niacin ER
Drug: Aspirin

First Posted Date: 2006-03-08

Last Posted Date: 2017-07-28

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 38

Registration Number: NCT00300365

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

A Study on the Use of Tanakan® for Recovery of Neurological Impairment Following Ischaemic Stroke

Phase 3

Completed

Conditions: Stroke, Acute
Neurological Impairment

Interventions: Drug: EGb761
Drug: Placebo
Drug: Acetylsalicylic acid

First Posted Date: 2006-01-13

Last Posted Date: 2019-01-08

Lead Sponsor: Ipsen

Target Recruit Count: 204

Registration Number: NCT00276380

Locations: 🇨🇿
General Faculty Hospital, Prague 2, Czechia
🇨🇿
Faculty of Medicine in Hradec Kralove, Hradec Kralove, Czechia
🇷🇴
Institul de Boli Cerebro Vascular, Bucharest, Romania

and more 7 locations

Cilostazol in Acute Ischemic Stroke Treatment (CAIST)

Phase 4

Completed

Conditions: Cerebral Infarction

First Posted Date: 2006-01-06

Last Posted Date: 2009-12-16

Lead Sponsor: Korea Otsuka Pharmaceutical Co., Ltd.

Target Recruit Count: 468

Registration Number: NCT00272454

Locations: 🇰🇷
Hallym University Sacred Heart Hospital, Ahnyang, Kyunggi Province, Korea, Republic of
🇰🇷
Inje University Ilsan Paik Hospital, Koyang, Kyunggi Province, Korea, Republic of
🇰🇷
Seoul National University Bundang Hospital, Sungnam, Kyunggi Province, Korea, Republic of

and more 8 locations

Aspirin/Folate Prevention of Large Bowel Polyps

Phase 2

Completed

Conditions: Adenomas
Colorectal Cancer
Polyps

First Posted Date: 2006-01-05

Last Posted Date: 2020-03-13

Lead Sponsor: Dartmouth-Hitchcock Medical Center

Target Recruit Count: 1121

Registration Number: NCT00272324

Locations: 🇺🇸
University of Colorado, Denver, Colorado, United States
🇺🇸
USC/Kaiser, Los Angeles, California, United States
🇨🇦
University of Toronto, Toronto, Ontario, Canada

and more 6 locations